Amondys 45
SRPT-Dup-US-001
Phase 2 small_molecule completed
Quick answer
Amondys 45 for Duchenne Muscular Dystrophy is a Phase 2 program (small_molecule) at Sarepta Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sarepta Therapeutics
- Indication
- Duchenne Muscular Dystrophy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed